Treatment of KPARG12C tumours with RMC-4998 and RMC-4550 for 2 days resulted in decreased expression of Dusp6 which indicated suppression of MAPK pathway (Supplementary Fig. 3a), consistent with our in vitro observations (Supplementary Fig. 1d). The gene discussed is DUSP6; the disease is neoplasm.